Mukka Proteins Limited (NSE:MUKKA)
India · Delayed Price · Currency is INR 23.04
+0.09 (0.39%)
May 27, 2026, 3:29 PM IST
Mukka Proteins Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 14,035 | 10,064 | 13,798 | 11,771 | 7,705 |
Other Revenue | 459.39 | - | - | 13.99 | 14.36 |
| 14,495 | 10,064 | 13,798 | 11,785 | 7,719 | |
Revenue Growth (YoY) | 44.02% | -27.06% | 17.08% | 52.67% | 27.68% |
Cost of Revenue | 11,693 | 7,760 | 11,367 | 9,429 | 6,358 |
Gross Profit | 2,801 | 2,304 | 2,431 | 2,356 | 1,362 |
Selling, General & Admin | 407.75 | 332.22 | 297.61 | 249.05 | 205.38 |
Other Operating Expenses | 1,248 | 1,005 | 1,051 | 1,227 | 655.19 |
Operating Expenses | 1,821 | 1,472 | 1,472 | 1,595 | 946.64 |
Operating Income | 979.9 | 831.9 | 959.17 | 761.01 | 414.97 |
Interest Expense | -535.96 | -266.17 | -189.92 | -116.21 | -75.59 |
Interest & Investment Income | - | 37.29 | 31.66 | 16.81 | 13.09 |
Earnings From Equity Investments | 20.69 | 10.68 | 31.06 | 14.6 | 10.12 |
Currency Exchange Gain (Loss) | - | 80.94 | 92.87 | - | 11.24 |
Other Non Operating Income (Expenses) | 286.8 | -92.69 | -54.24 | -27.96 | -15.4 |
EBT Excluding Unusual Items | 751.43 | 601.95 | 870.6 | 648.25 | 358.43 |
Gain (Loss) on Sale of Investments | - | 0.16 | - | - | - |
Gain (Loss) on Sale of Assets | - | 0.55 | 3.95 | -2.66 | 0.93 |
Other Unusual Items | - | - | - | 1.33 | - |
Pretax Income | 751.43 | 602.66 | 874.55 | 659.43 | 359.8 |
Income Tax Expense | 180.57 | 121.69 | 131.5 | 184.18 | 101.61 |
Earnings From Continuing Operations | 570.86 | 480.97 | 743.05 | 475.25 | 258.19 |
Minority Interest in Earnings | -50.28 | -16.38 | -42.53 | -34.5 | -16.11 |
Net Income | 520.58 | 464.59 | 700.52 | 440.75 | 242.08 |
Net Income to Common | 520.58 | 464.59 | 700.52 | 440.75 | 242.08 |
Net Income Growth | 12.05% | -33.68% | 58.94% | 82.07% | 169.70% |
Shares Outstanding (Basic) | 299 | 300 | 226 | 220 | 220 |
Shares Outstanding (Diluted) | 299 | 300 | 226 | 220 | 220 |
Shares Change (YoY) | -0.27% | 32.93% | 2.58% | - | - |
EPS (Basic) | 1.74 | 1.55 | 3.10 | 2.00 | 1.10 |
EPS (Diluted) | 1.74 | 1.55 | 3.10 | 2.00 | 1.10 |
EPS Growth | 12.36% | -50.11% | 54.94% | 82.13% | 169.61% |
Free Cash Flow | -2,495 | -1,360 | -1,680 | -655.62 | -17.03 |
Free Cash Flow Per Share | -8.34 | -4.54 | -7.45 | -2.98 | -0.08 |
Gross Margin | 19.33% | 22.89% | 17.62% | 19.99% | 17.64% |
Operating Margin | 6.76% | 8.27% | 6.95% | 6.46% | 5.38% |
Profit Margin | 3.59% | 4.62% | 5.08% | 3.74% | 3.14% |
Free Cash Flow Margin | -17.21% | -13.52% | -12.18% | -5.56% | -0.22% |
EBITDA | 1,146 | 948.83 | 1,082 | 879.74 | 496.42 |
EBITDA Margin | 7.90% | 9.43% | 7.84% | 7.46% | 6.43% |
D&A For EBITDA | 165.92 | 116.93 | 123.19 | 118.73 | 81.45 |
EBIT | 979.9 | 831.9 | 959.17 | 761.01 | 414.97 |
EBIT Margin | 6.76% | 8.27% | 6.95% | 6.46% | 5.38% |
Effective Tax Rate | 24.03% | 20.19% | 15.04% | 27.93% | 28.24% |
Revenue as Reported | 14,781 | 10,215 | 13,961 | 11,838 | 7,761 |
Advertising Expenses | - | - | - | - | 6.22 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.